<p align="left" style="margin-right: 0px; margin-left: 0px; padding: 0px; color: rgb(85, 85, 85); font-family: 'Noto Sans KR', 돋움, dotum, sans-serif; font-size: 14px; box-sizing: border-box; letter-spacing: -0.25px; background-color: rgb(255, 255, 255);"><b style="margin: 0px; padding: 0px; box-sizing: border-box;">□ 글로벌 바이오제약사의 라이센싱 파트너십 거래 현황을 살펴보면, 2021년 이래 거래 건수는 줄고 있으나 2023년 4분기에 ADC 개발 협업으로 거래 금액이 급증하였음</b></p> <p align="left" style="margin-right: 0px; margin-left: 0px; padding: 0px; color: rgb(85, 85, 85); font-family: 'Noto Sans KR', 돋움, dotum, sans-serif; font-size: 14px; box-sizing: border-box; letter-spacing: -0.25px; background-color: rgb(255, 255, 255);"><br></p> <p align="left" style="margin-right: 0px; margin-left: 0px; padding: 0px; color: rgb(85, 85, 85); font-family: 'Noto Sans KR', 돋움, dotum, sans-serif; font-size: 14px; box-sizing: border-box; letter-spacing: -0.25px; background-color: rgb(255, 255, 255);"> </p> <p align="left" style="margin-right: 0px; margin-left: 0px; padding: 0px; color: rgb(85, 85, 85); font-family: 'Noto Sans KR', 돋움, dotum, sans-serif; font-size: 14px; box-sizing: border-box; letter-spacing: -0.25px; background-color: rgb(255, 255, 255);"><b style="margin: 0px; padding: 0px; box-sizing: border-box;">□ 질환분야는 항암제, 모달리티는 바이오의약품에 대한 라이센싱 활동이 가장 활발</b></p> <p align="left" style="margin-right: 0px; margin-left: 0px; padding: 0px; color: rgb(85, 85, 85); font-family: 'Noto Sans KR', 돋움, dotum, sans-serif; font-size: 14px; box-sizing: border-box; letter-spacing: -0.25px; background-color: rgb(255, 255, 255);"><br></p> <p align="left" style="margin-right: 0px; margin-left: 0px; padding: 0px; color: rgb(85, 85, 85); font-family: 'Noto Sans KR', 돋움, dotum, sans-serif; font-size: 14px; box-sizing: border-box; letter-spacing: -0.25px; background-color: rgb(255, 255, 255);"><b style="margin: 0px; padding: 0px; box-sizing: border-box;"> </b></p> <p align="left" style="margin-right: 0px; margin-left: 0px; padding: 0px; color: rgb(85, 85, 85); font-family: 'Noto Sans KR', 돋움, dotum, sans-serif; font-size: 14px; box-sizing: border-box; letter-spacing: -0.25px; background-color: rgb(255, 255, 255);"><span style="font-weight: bold;">□</span> <b style="margin: 0px; padding: 0px; box-sizing: border-box;">이러한 대형 제약사들의 디-리스크(de-risk) 전략은 신약개발 단계별 거래 현황에서도 나타나고 있음. </b></p> <p align="left" style="margin-right: 0px; margin-left: 0px; padding: 0px; color: rgb(85, 85, 85); font-family: 'Noto Sans KR', 돋움, dotum, sans-serif; font-size: 14px; box-sizing: border-box; letter-spacing: -0.25px; background-color: rgb(255, 255, 255);"><b style="margin: 0px; padding: 0px; box-sizing: border-box;">  2023년 한해 대형 제약사들은 기술거래 투자에 대한 리스크를 완화하기 위해 개발 초기 단계보다는 중후기 단계의 거래로 전환하기 시작했음.</b></p> <p align="left" style="margin-right: 0px; margin-left: 0px; padding: 0px; color: rgb(85, 85, 85); font-family: 'Noto Sans KR', 돋움, dotum, sans-serif; font-size: 14px; box-sizing: border-box; letter-spacing: -0.25px; background-color: rgb(255, 255, 255);">   </p>
소스입니다. Ctrl+C를 눌러 클립보드로 복사하세요

닫기